HALOZYME THERAPEUTICS, INC. Logo

HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
12390 EL CAMINO REAL, 92130 SAN DIEGO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Evaxion A/S Logo
Develops AI-powered, personalized vaccines for cancer and infectious diseases.
United States of America EVAX
Evogene Ltd. Logo
AI-powered computational biology developing products for health, agriculture, and industry.
United States of America EVGN
Evogene Ltd. Logo
AI-powered platform designing life-science solutions for health, ag, and industrial sectors.
Israel EVGN
Evotec SE Logo
A drug discovery partner accelerating medicine creation from R&D to manufacturing for pharma/biotech.
United States of America EVO
EXACT Therapeutics AS Logo
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
Norway EXTX
Offers performance-based advertising and CPA solutions via Japan's largest affiliate network.
Japan 2461
Back-office outsourcing & consulting in accounting, finance, and HR for SMEs & sole proprietors.
Japan 4771
Foremost Clean Energy Ltd. Logo
Canadian explorer of uranium and lithium for the clean energy sector.
United States of America FMST
Forte Biosciences, Inc. Logo
Clinical-stage biopharma developing FB102 for autoimmune diseases like celiac, vitiligo, & alopecia.
United States of America FBRX
Fortrea Holdings Inc. Logo
Global CRO managing clinical trials for the biopharmaceutical and medical device industries.
United States of America FTRE

Talk to a Data Expert

Have a question? We'll get back to you promptly.